Clinical study to evaluate the efficacy and tolerability of the Meneguetti brush for self-collection of anal specimens to screen for anal cancer and sexually transmitted infections
Not Applicable
- Conditions
- Anal CancerSexually Transmitted Diseases (STD)C04.588.274.476.411.307.790
- Registration Number
- RBR-6nxst93
- Lead Sponsor
- Instituto Nacional de Infectologia Evandro Chagas - Fiocruz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
We will include participants 18 years or older, with no history of anal cancer or pelvic radiotherapy, who did not participate in Phase 1 of the study, who are being followed up for HIV or HIV prevention at the Instituto Nacional de Infectologia Evandro Chagas-INI/Fiocruz.
Exclusion Criteria
Participants under the age of 18, participants who have had topical anal medication within the past 30 days or surgical treatment within the past 6 months, anal cytology performed within the past 3 months, or who have anal complaints at the time of recruitment.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To demonstrate that the sample obtained by means of the Meneguetti brush is suitable for analysis by liquid cytology.
- Secondary Outcome Measures
Name Time Method Demonstrate the safety of the brush to allow collection in the home environment and basic health units or in clinical analysis laboratories.